MENU
RNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rein Therapeutics (RNTX) Earnings Date & Reports
Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments... Show more
A.I. Advisor
published Earnings
RNTX is expected to report earnings to fall 55.05% to -49 cents per share on August 12
Q2'26
Est.
$-0.49
Q4'25
Missed
by $0.92
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.07
Q1'25
Est.
$-0.25
The last earnings report on March 26 showed earnings per share of -109 cents, missing the estimate of -17 cents. With 308.70K shares outstanding, the current market capitalization sits at 77.80M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information